Life-saving cancer drug restricted

13 December 2016 - A British Colombia woman says a new immuno-oncology drug that saved her life is not available ...

Read more →

CADTH publishes final outcome for Afinitor (everolimus)

1 December 2016 - The outcome relates to the use of everolimus for the treatment of patients with a neuroendocrine ...

Read more →

CADTH publishes final outcome for Darzalex (daratumumab)

1 December 2016 - The outcome relates to the use of daratumumab for the treatment of patients with multiple myeloma. ...

Read more →

CADTH publishes initial recommendation for Venclexta (venetoclax)

1 December 2016 - The outcome relates to the use of venetoclax for the treatment of patients with chronic lymphocytic ...

Read more →

CADTH issues second final recommendation for Ibrance (palbociclib)

21 November 2016 - CADTH has published a final outcome for palbociclib following a resubmission from Pfizer. ...

Read more →

Exciting new MAESTrO feature

18 November 2016 - Users can now develop and export images within the application. ...

Read more →

Too much chemotherapy

10 November 2016 - People with cancer are living longer now than 40 years ago. This is clearly good news. But ...

Read more →

Breast cancer chemotherapy costs vary despite similar effectiveness

11 October 2016 - Chemotherapy regimens for breast cancer can vary wildly in price even when they are comparable in ...

Read more →

As world embraces precision medicine, Canada falls behind

4 October 2016 - The United States is going to analyze the genetic information of more than one million Americans. The ...

Read more →

CADTH publishes initial recommendation for Darzalex (daratumumab)

29 September 2016 - CADTH has published its initial take on the reimbursement of Darzalex for patients with multiple myeloma. ...

Read more →

CADTH issues final recommendation for Lynparza

29 September 2016 - CADTH has published its final outcome for Lynparza. ...

Read more →

CADTH posts final recommendation for Zydelig

29 September 2016 - CADTH has published its final recommendation for Zydelig for follicular lymphoma. ...

Read more →

CADTH issues initial pERC outcome for Lynparza (olaparib)

5 August 2016 - CADTH has published pERC's initial recommendation on the use of olaparib for use as monotherapy maintenance treatment ...

Read more →

CADTH issues final pERC outcome for Yondelis (trabectedin)

5 August 2016 - CADTH has published pERC's final recommendation on the use of trabectedin for patients with metastatic liposarcoma ...

Read more →

pERC issues final recommendation for Imbruvica (ibrutinib)

19 July 2016 - Canada's pCODR Expert Review Committee has issued a final recommendation for Janssen's ibrutinib for patients with ...

Read more →